Afya Limited Class A Common Shares

AFYA

Afya Limited is a healthcare education company primarily focused on providing medical, dental, and other health sciences training in Latin America. The company operates through a network of universities and professional training centers, offering undergraduate and postgraduate programs to meet the growing demand for healthcare professionals in the region. Afya aims to expand access to quality health education and improve healthcare quality through its educational offerings.

$14.32 0.00 (0.00%)
Payout Frequency

Dividend History

Pay DateAmountEx-DateRecord Date
April 4, 2025$0.232025-03-262025-03-26

Dividends Summary

Company News

Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion - Zacks Investment Research
Zacks Investment Research • Zacks.Com • July 22, 2024

The article discusses 5 top small-cap stocks that are Zacks Rank #1 (Strong Buy) or #2 (Buy) stocks, including Soundhound AI, Afya, Castle Biosciences, TriMas, and Immersion. The article provides an overview of each company's business, market cap, stock performance, and earnings growth outlook.

AFYA Welcomes 300 Operational Medical School Seats in Salvador
Zacks Investment Research • Zacks Equity Research • July 2, 2024

AFYA boosts its medical education service offerings by acquiring Unidompedro, which offers 300 operational medical school seats in Salvador.

Zacks.com featured highlights include Afya, Despegar.com, Kelly Services and Norsk Hydro
Zacks Investment Research • Zacks Equity Research • July 2, 2024

Afya, Despegar.com, Kelly Services and Norsk Hydro are part of the Zacks Screen of the Week article.

4 Best GARP Picks for Your Portfolio Based on Discounted PEG
Zacks Investment Research • Urmimala Biswas • July 1, 2024

Here are four stocks that perfectly fit our screening criteria based on discounted PEG. They are AFYA, DESP, KELYA and NHYDY.

Wall Street Analysts Think Afya (AFYA) Could Surge 32.79%: Read This Before Placing a Bet
Zacks Investment Research • Zacks Equity Research • June 28, 2024

The average of price targets set by Wall Street analysts indicates a potential upside of 32.8% in Afya (AFYA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Related Companies